Why Domo Stock Rocketed More Than 16% Higher Today

Domo (NASDAQ: DOMO) shares surged over 16% after TD Cowen analyst Derrick Wood upgraded the data analytics company to 'Buy' from 'Hold,' simultaneously increasing his price target by nearly 62% to $21. Wood cited Domo's strategic shift to consumption-based pricing, which he believes will enhance adoption and monetization, and positioned the firm as an attractive 'next-generation data and infrastructure' play amidst growing investor demand. This upgrade precedes Domo's Q2 fiscal 2026 earnings release and follows a Q1 report that showed a narrowed net loss and a 24% increase in remaining performance obligations despite flat revenue.

Analysis

Domo (DOMO) experienced a significant positive catalyst ahead of its scheduled second-quarter earnings release, with its share price surging over 16% following an analyst upgrade. TD Cowen analyst Derrick Wood raised his recommendation from 'Hold' to 'Buy' and increased the price target by nearly 62% to $21 per share. The core of this bullish thesis rests on two key pillars: a strategic pivot from a per-seat to a consumption-based pricing model, which is anticipated to drive both wider adoption and improved monetization, and Domo's positioning as an undervalued asset within the limited field of publicly-traded, next-generation data infrastructure companies. This optimism is partially substantiated by fundamentals from the prior quarter (Q1), where despite flat year-over-year revenue, the company achieved a considerable reduction in its net loss and posted a steep 24% increase in remaining performance obligations (RPOs), a key indicator of future contracted revenue.

Key Decisions for Investors

• Investors should closely scrutinize the upcoming Q2 earnings report for confirmation of the analyst's thesis, specifically looking for early evidence of success from the new consumption-based pricing model and continued strong growth in remaining performance obligations.
• Given the stock's 16% pre-earnings rally, it is prudent to weigh the potential upside of the $21 price target against the execution risk and the heightened expectations now priced into the shares.
• Consider the conflicting signals of flat Q1 revenue versus strong RPO growth and narrowing losses; a key decision is whether to view this as a successful turnaround in progress or to wait for top-line growth to re-accelerate before increasing exposure.